Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Monthly Archives: October 2017

VENDORS EVENT: HINJ and Somerset County Business Partnership to Host 2017 Life Sciences Vendors Procurement Conference on November 2

New Brunswick, NJ, October 20, 2017 — The HealthCare Institute of New Jersey’s (HINJ) annual Life Sciences Vendors Procurement Conference is scheduled for Thursday, November 2 from 8:00 to 11:30 a.m. at Raritan Valley Community College, Route 28 and Lamington Road, North Branch, NJ.

The event — entitled “How to Do Business with Pharma and Medical Technology Companies” — will be co-sponsored by the Somerset County Business Partnership (SCBP) with support from Eli Lilly and Company and Allergan.

Senator Kip Bateman (R-Somerset) will be the special guest speaker at the event that aims to educate businesses, large and small, on trends in procurement and issues of importance to the industry. Continue reading

Rutgers Biomedical and Health Sciences Dedicates RBHS-South in Blackwood; Expands Rutgers’ Partnership with Camden County College

Blackwood, NJ, October 20, 2017 — With a snip of a scarlet ribbon, Rutgers School of Biomedical and Health Sciences Chancellor Brian Strom officially opened the new RBHS-South campus in South Jersey.

On the grounds of Camden County College, the campus hosts graduate and undergraduate School of Health Profession programs in three disciplines, as well as a School of Nursing bachelor’s degree program.

“The partnership between Rutgers Biomedical and Health Sciences and Camden County College offers more health science education in a collaborative environment,” said Chancellor Strom at the event held on the campus October 12. Continue reading

Hackensack University Medical Center Foundation Receives Donation from Celgene to Advance Multiple Myeloma Research at John Theurer Cancer Center

Former Roche campus to be new Seton Hall-Hackensack Meridian School of Medicine

Hackensack, NJ, October 20, 2017 — The Hackensack University Medical Center Foundation announced on October 5 that it has received a substantial donation from Celgene Corporation to advance multiple myeloma research and transformational medicine that improve patient outcomes at Hackensack Meridian Health–John Theurer Cancer Center.

Supported by Celgene, a global biopharmaceutical leader in the discovery, development and delivery of treatment for diseases like multiple myeloma (MM), funds will help to establish the Multiple Myeloma Institute (MMI) — a leading-edge research facility at the Seton Hall-Hackensack Meridian School of Medicine scheduled to open in 2018.

Celgene and John Theurer Cancer Center are accomplished leaders in developing novel therapies for patients with multiple myeloma. Continue reading

Dr. Norman Sharpless Sworn in as Director of the National Cancer Institute

Dr. Norman “Ned” Sharpless

Bethesda, MD, October 19, 2017 — Norman E. “Ned” Sharpless, M.D., took the oath of office October 17 to become the 15th director of the National Cancer Institute (NCI), part of the National Institutes of Health. H

Dr. Sharpless succeeds Harold E. Varmus, M.D., who stepped down as director in March 2015. Douglas R. Lowy, M.D., has been NCI’s acting director since April 2015.

“It is an honor to welcome Dr. Sharpless to the Department of Health and Human Services and the National Institutes of Health,” said Acting Health and Human Services Secretary Eric D. Hargan. Continue reading

ExxonMobil Expanding New Jersey Research and Engineering Center in Clinton

Clinton, NJ, October 19, 2017 — ExxonMobil announced on October 13 that it has broken ground on the expansion of its research facility in Clinton, NJ, a key center of innovation that supports the company’s broad research and development programs.

Expansion of the facility, home to ExxonMobil’s fundamental and process research and development, including advancing algae biofuel and carbon capture technologies, is expected to be completed in 2019 and will include employees relocating from its research facility in Paulsboro, NJ. Continue reading

JerseyCAN’s New Report Explores STEM Innovations in NJ and Preparing Today’s Students for Tomorrow’s Jobs

Trenton, NJ, October 19, 2017JerseyCAN last week released a new report, Preparing the Children of Today for the Jobs of Tomorrow: A Window into STEM Education in New Jersey, highlighting STEM innovations across New Jersey.

JerseyCAN met with over 70 individuals and organizations leading pioneering work in STEM education including: superintendents, principals, teachers, students, think tanks, foundations, corporate leaders, scientific institutions, the military, state leaders and academics. Continue reading

Rowan, Rutgers, Camden County College Partner on Health Sciences; Joint Health Sciences Center Construction Begins

Camden, NJ, October 18, 2017 — With a ceremonial groundbreaking on October 19, local, state and federal officials are joining with the Rowan University/Rutgers-Camden Board of Governors (Joint Board of Governors) to celebrate the beginning construction of the Joint Health Sciences Center, an innovative facility that will provide unique education and training opportunities to a new generation of health care providers.

Set to open in the spring of 2019 at the intersection of Martin Luther King Blvd. and Broadway in downtown Camden, the Joint Health Sciences Center will be the first of its kind in New Jersey.

The construction of the 95,000 square-foot building will generate approximately $72 million in economic impact in the City of Camden alone.  Continue reading

Event: HINJ and Rutgers Biomedical Engineering Medical Device Development Center to Host Cybersecurity for Medical Devices’ on October 19; Second in Forum Series

New Brunswick, NJ, October 18, 2017 — Please join the Rutgers Biomedical Engineering Medical Device Development Center and the HealthCare Institute of New Jersey (HINJ) on Thursday, October 19 for “Cybersecurity for Medical Devices: Why and How,” which is the second in their Fall 2017 series of educational panels and seminars that focus on the medical device industry.

The forum will be held from 5:00 to 7:00 p.m. at Rutgers University Easton Auditorium (Busch Campus), 101 Bevier Road, Piscataway.  A networking reception will begin at 5:00 p.m.; the program will start at 5:30 p.m.

Medical device vulnerability to cybercrime is increasing, creating threats that can result in hospital data theft, patient identity theft and potential harmful impact to medical device safety and effectiveness.  Continue reading

Two New Jersey Residents Among 2017 MacArthur Foundation’s ‘Genius Grants’

Newark, NJ, October 18, 2017 — The MacArthur Foundation announced October 11 the 2017 recipients of its fellowship program, a prestigious award that promotes creativity and innovation with $625,000 awards.

Two of the 2017 class of MacArthur’s “genius grants” will go to two New Jersey residents, Jess Mazzola reported in The Star-Ledger/NJ.com.

The foundation describes the awards as “no-strings-attached” funding that goes to “extraordinarily talented and creative individuals as an investment in their potential.” Continue reading

NJ Innovation Institute and Rutgers Announce Plans to Form the New Jersey Continuous Manufacturing Institute to Advance Pharmaceutical Industry

Newark, NJ, October 17, 2017 — The New Jersey Innovation Institute (NJII), an NJIT Corporation, and Rutgers University announce plans to form the New Jersey Continuous Manufacturing Institute (NJCMI) to advance innovative manufacturing technologies in the pharmaceutical industry.

The NJCMI serves as a center of excellence combining state-of-the-art technologies, infrastructure, facilities and technical expertise to support the development and continuous manufacturing of products for the pharmaceutical industry.

In addition, it provides training, education and workforce development solutions for those who want to expand or gain additional training and expertise in pharmaceutical manufacturing. Continue reading